Navigation Links
iGATE Completes Phase I Testing Of Meningitis Vaccine

Contract research firm iGATE Clinical Research International today completed the Phase I clinical trial of a new meningococcal-A conjugate vaccine. //

The project, which is being done in partnership between the World Health Organization (WHO) and the Program for Appropriate Technology in Health (PATH), an American NGO based in Seattle aimed at eliminating epidemic meningitis in sub-Saharan Africa.

Vaccine development partners include the Center for Biologics Evaluation and Research (CBER - a centre of the United States Food and Drug Administration for conjugation technology, and Serum Institute of India Limited (SIIL) for vaccine manufacturing, a company release said here today.

IGATE CRI was awarded a five-year contract by Meningitis Vaccine Project (MVP) for clinical trial services spanning Phase I to Phase III testing that will include seven clinical trials.

The new meningococcal A vaccine is manufactured by Serum Institute of India Limited (SIIL).

IGATE CRI commenced monitoring Phase I trials in September 2004 in India and expects to initiate work on Phase II trials this year. The Phase I trial of the new vaccine was conducted in 72 subjects across three sites in India, the release said.

Source:PTI News
'"/>




Page: 1

Related medicine news :

1. Delhi Hospital Completes 100 Liver Transplants
2. SARS-Free Taiwan to Mark End Phase of Global Fight
3. Spray on contraceptive clears Phase I trial
4. Phase 3 trials of two multi-kinase inhibitors against cancer
5. Antigenics Pharmaceuticals plans for Phase III trial of its Melanoma vaccine
6. Phase II trails of new HIV vaccine to be held in South Africa
7. FDA approves Phase 0 trial which tests experimental drugs on humans
8. Jalgaon: Third Phase Of Culling Operations Begin
9. Phase 1 Drug Trials on Humans to Be Made Public
10. Lupin Gets DCGI Nod For Phase II Clinical Trials On Desoside-P
11. Cadila to Commence Phase I Clinical Trials On ZYH2
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: ... “America On The Brink” is the creation of published author, William Nowers. ... As a WWII veteran, he spent thirty years in the Navy. Following ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company has developed a ... and regulatory authorities worldwide. From Children’s to Adults 50+, every formula has been ... standard. , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... that we intend to develop to enable prevention of a major side effect ... hearing loss, especially in pediatric patients. For cisplatin, hearing loss is FDA listed ...
(Date:10/12/2017)... ... October 12, 2017 , ... On Saturday, October 21, ... relay – Miles by Moonlight to raise money for the American Heart Association Heart ... , Teams will work together to keep their treadmills moving for 5 hours. ...
(Date:10/12/2017)... FL (PRWEB) , ... October 12, 2017 , ... ... presenting the latest in wound care advancements to physician colleagues, skilled nursing facility ... is titled, "Navigating the Treacherous Waters of Wound Care." , "At many of ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... , Oct. 2, 2017  Eli Lilly and ... financial results for the third quarter of 2017 on ... conference call on that day with the investment community ... The conference call will begin at 9 ... can access a live webcast of the conference call ...
(Date:10/2/2017)... , Oct. 2, 2017 Halo Labs announces the European ... system called the HORIZON at MIBio 2017 in Cambridge, ... and visible particulate matter in biopharmaceutical samples with unprecedented speed and ... the novel technique Backgrounded Membrane Imaging. ... The HORIZON subvisible particle analysis system ...
(Date:9/28/2017)... , Sept. 28, 2017 Hill-Rom Holdings, ... 2017 earnings conference call and webcast on Friday, November ... a.m. (EDT) and ending at approximately 8:30 a.m. (CDT) ... discussing the company,s 2017 financial performance and guidance for ... opportunities, initiatives to enhance operational performance, and long-range financial ...
Breaking Medicine Technology: